Tuesday, 17 March 2026
PERSPECTA
News from every angle
All
World
Politics
Business
Technology
Finance
Science
Health
Sport
Culture
Opinion
Environment
← Back to headlines
Eli Lilly Falls 5% — FDA Oral Obesity Pill Decision and Novo Nordisk Rivalry Weigh on Shares
17 Mar, 16:27 — 17 Mar, 16:27
Post
Share
Copy link
Embed
Sources
Sort: Relevance
Sort: Latest
Sort: Bias (L→R)
Sort: Bias (R→L)
Sort: Factuality
left
center
right
Showing 1 of 1 sources
Yahoo
Mostly Factual
1h ago
Eli Lilly Falls 5% — FDA Oral Obesity Pill Decision and Novo Nordisk Rivalry Weigh on Shares
Read full article →
Something wrong with this story? Report an issue
Related Stories
Ernakulam records highest number of hepatitis A cases in Kerala
6m ago
Benue records 383 suspected Lassa Fever cases, 47 confirmed
9m ago
Working Meeting of the Hellenic Patients' Association with the New Management of IFET
10m ago
Candel gains on additional mid-stage trial data for lead asset
16m ago
Tuesday, 17 March 2026
Explore
Log in
Sign up
PERSPECTA
News from every angle
